Do Weight-Loss drugs alter your senses? new study investigates

NCT ID NCT07611201

Completed Knowledge-focused Sponsor: Purdue University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study from Purdue University looked at whether GLP-1 receptor agonists (like Ozempic or Wegovy) change how people taste, smell, and crave food. Researchers compared 90 adults with obesity who were either not taking the drug, or had been taking it for about 1 month or 6 months. Participants completed taste and smell tests, food preference tasks, and questionnaires. The study did not provide any medication—it only observed differences between groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help explain how GLP-1 drugs change taste and smell, potentially leading to better weight management strategies.
What could go wrong: This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APPETITE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anosmia Feeding Behavior Food Preferences Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APPETITE EATING BEHAVIOR OBESITY OLFACTION OVERWEIGHT TASTE PERCEPTION

Contacts and locations

Locations

Purdue University

West Lafayette, Indiana, 47906, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.